RT Journal Article
SR Electronic
T1 Memory recovery is related to default mode network impairment and neurite density during brain tumours treatment
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 19008581
DO 10.1101/19008581
A1 Romero-Garcia, R
A1 Suckling, J
A1 Owen, M
A1 Assem, M
A1 Sinha, R
A1 Coelho, P
A1 Woodberry, E
A1 Price, SJ
A1 Burke, GAA
A1 Santarius, T
A1 Erez, Y
A1 Hart, MG
YR 2020
UL http://medrxiv.org/content/early/2020/10/22/19008581.abstract
AB Surgical resection is an effective treatment to delay brain tumour progression and improve survival. Nevertheless, a large proportion of patients have treatment-induced memory deficits that dramatically reduce their life quality. Our aim is to test brain tumour interactions with brain networks thereby identifying protective features and risk factors for memory recovery. Seventeen patients with diffuse glioma (aged 22-56 years) were MRI-scanned and cognitively assessed before and after surgery, and during a 12-months recovery period (47 MRI in total after exclusion). Using structural MRI and Neurite Orientation Dispersion and Density Imaging (NODDI) derived from diffusion-weighted images, we respectively estimated lesion overlap and Neurite Density with brain networks derived from normative data in healthy participants. Non-local effects of tumours were evident on neurite density, which was reduced not only within the tumour, but also beyond the tumour boundary. In contrast, high preoperative neurite density outside the tumour, but within the DMN, was associated with better memory recovery. Furthermore, follow-up neurite density within the DMN and Frontoparietal network were also associated with memory recovery. Preoperative tumour, and post-operative lesion, overlap with the DMN showed a significant negative association with memory recovery. Our findings suggest that brain tumours and their corresponding treatment affecting brain networks that are fundamental for memory functioning such as the DMN can have a major impact on patient’s memory recovery.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported by The Brain Tumour Charity and the Guarantors of Brain (RG91650).Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.YesData is not currently available